DUBLIN, Calif.--(BUSINESS WIRE)--Astex Pharmaceuticals, Inc. (NASDAQ:ASTX), a pharmaceutical company dedicated to the discovery, development and commercialization of novel cancer therapies, announced that it will release its 2011 third quarter financial results on Monday, October 31, 2011. James S.J. Manuso, Ph.D., chairman and chief executive officer, and the Astex Pharmaceuticals management team, will provide details of the Company’s financial results and revised outlook for the future.
